4//SEC Filing
Dulac Edward J III 4
Accession 0001193125-26-006275
CIK 0001652130other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:02 PM ET
Size
4.8 KB
Accession
0001193125-26-006275
Insider Transaction Report
Form 4
Dulac Edward J III
EVP, Chief Financial Officer
Transactions
- Sale
Common Stock
2026-01-05$9.21/sh−6,379$58,751→ 99,683 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001821530
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:02 PM ET
- Size
- 4.8 KB